275 related articles for article (PubMed ID: 34481721)
1. Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives.
Wijnands AM; Mahmoud R; Lutgens MWMD; Oldenburg B
Eur J Intern Med; 2021 Nov; 93():35-41. PubMed ID: 34481721
[TBL] [Abstract][Full Text] [Related]
2. Interval Colorectal Cancer in Inflammatory Bowel Disease: A Review.
Da Cunha T; Vaziri H
J Clin Gastroenterol; 2024 Jan; 58(1):1-11. PubMed ID: 37548445
[TBL] [Abstract][Full Text] [Related]
3. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
5. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
[TBL] [Abstract][Full Text] [Related]
6. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
[TBL] [Abstract][Full Text] [Related]
7. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Mpofu C; Watson AJ; Rhodes JM
Cochrane Database Syst Rev; 2004; (2):CD000279. PubMed ID: 15106148
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer surveillance in inflammatory bowel disease: the search continues.
Ahmadi A; Polyak S; Draganov PV
World J Gastroenterol; 2009 Jan; 15(1):61-6. PubMed ID: 19115469
[TBL] [Abstract][Full Text] [Related]
9. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
Axelrad JE; Faye A; Slaughter JC; Harpaz N; Itzkowitz SH; Shah SC
Inflamm Bowel Dis; 2022 Jun; 28(6):855-861. PubMed ID: 34319381
[TBL] [Abstract][Full Text] [Related]
10. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Collins PD; Mpofu C; Watson AJ; Rhodes JM
Cochrane Database Syst Rev; 2006 Apr; (2):CD000279. PubMed ID: 16625534
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic surveillance of colorectal cancer in inflammatory bowel diseases: a review of the literature.
Vitello A; Shahini E; Macaluso FS; Morreale GC; Sinagra E; Pallio S; Maida M
Expert Rev Anticancer Ther; 2020 Oct; 20(10):851-863. PubMed ID: 32811225
[TBL] [Abstract][Full Text] [Related]
12. Updates in colorectal cancer screening in inflammatory bowel disease.
Clarke WT; Feuerstein JD
Curr Opin Gastroenterol; 2018 Jul; 34(4):208-216. PubMed ID: 29771698
[TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer Screening in Inflammatory Bowel Disease.
Sengupta N; Yee E; Feuerstein JD
Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
[TBL] [Abstract][Full Text] [Related]
14. Carcinogenesis in inflammatory bowel disease.
Herszenyi L; Miheller P; Tulassay Z
Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
[TBL] [Abstract][Full Text] [Related]
15. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West).
Soetikno R; Kaltenbach T; McQuaid KR; Subramanian V; Kumar R; Barkun AN; Laine L
Dig Endosc; 2016 Apr; 28(3):266-73. PubMed ID: 26866420
[TBL] [Abstract][Full Text] [Related]
16. Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study.
Ballester MP; Mesonero F; Flórez-Diez P; Gómez C; Fuentes-Valenzuela E; Martín N; Senosiain C; Vela M; Fernández-Clotet A; Pérez P; Rubín de Célix C; Calviño-Suárez C; Hermida B; Muñoz R; González-Vivo M; Brunet E; Jiménez N; Botella B; Yebra J; Suárez-Ferrer C; Bouhmidi A; López-Serrano A; Ponferrada Á; Dueñas C; Mínguez M;
Aliment Pharmacol Ther; 2022 Jun; 55(11):1402-1413. PubMed ID: 35224758
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape.
Linson EA; Hanauer SB
Curr Gastroenterol Rep; 2021 Aug; 23(9):16. PubMed ID: 34338892
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the quality of endoscopy in inflammatory bowel disease: focus on surveillance and management of colorectal dysplasia using interactive image- and video-based teaching.
Kaltenbach TR; Soetikno RM; DeVivo R; Laine LA; Barkun A; McQuaid KR;
Gastrointest Endosc; 2017 Dec; 86(6):1107-1117.e1. PubMed ID: 28818507
[TBL] [Abstract][Full Text] [Related]
20. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
